Oric Pharmaceuticals, Inc.

Patents = 18

Trademarks = 2

Forward Citations = 35

where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents

42 inventors (with patents filed for the assignee):

ORIC Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies to treat cancer. They leverage their Precision Oncology Platform to discover and develop novel drugs that target mechanisms of resistance in cancer patients. With a deep understanding of tumor biology and drug resistance, ORIC Pharmaceuticals aims to improve outcomes for patients with cancer by developing effective and innovative treatments.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com